Australia Tendonitis Treatment Market Size & Outlook
The tendonitis treatment market in Australia is expected to reach a projected revenue of US$ 6,260.2 million by 2030. A compound annual growth rate of 5.6% is expected of Australia tendonitis treatment market from 2023 to 2030.
Revenue, 2022 (US$M)
$4,062.8
Forecast, 2030 (US$M)
$6,260.2
CAGR, 2023 - 2030
5.6%
Report Coverage
Australia
Australia tendonitis treatment market, 2018-2030 (US$M)
Related Markets
Australia tendonitis treatment market highlights
- The Australia tendonitis treatment market generated a revenue of USD 4,062.8 million in 2022 and is expected to reach USD 6,260.2 million by 2030.
- The Australia market is expected to grow at a CAGR of 5.6% from 2023 to 2030.
- In terms of segment, therapy was the largest revenue generating treatment in 2022.
- Surgery is the most lucrative treatment segment registering the fastest growth during the forecast period.
Tendonitis treatment market data book summary
| Market revenue in 2022 | USD 4,062.8 million |
| Market revenue in 2030 | USD 6,260.2 million |
| Growth rate | 5.6% (CAGR from 2022 to 2030) |
| Largest segment | Therapy |
| Fastest growing segment | Surgery |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Therapy, Surgery |
| Key market players worldwide | Merck & Co Inc, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Pfizer Inc, GSK PLC, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim Pharma, Almatica Pharma |
Other key industry trends
- In terms of revenue, Australia accounted for 1.9% of the global tendonitis treatment market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan tendonitis treatment market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,640.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tendonitis Treatment Market Scope
Tendonitis treatment market segmentation & scope
Tendonitis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia tendonitis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tendonitis treatment market will help companies and investors design strategic landscapes.
Therapy was the largest segment with a revenue share of 85.93% in 2022. Horizon Databook has segmented the Australia tendonitis treatment market based on therapy, surgery covering the revenue growth of each sub-segment from 2018 to 2030.
- Australia Tendonitis Treatment Treatment Outlook (Revenue, USD Million, 2018-2030)
- Therapy
- Hot and Cold Therapy
- Physical Therapy
- Shockwave Therapy
- Surgery
- Therapy
- Australia Tendonitis Treatment Condition Outlook (Revenue, USD Million, 2018-2030)
- Tennis Elbow
- Golfer’s Elbow
- Pitcher’s Elbow
- Jumper’s Knee
- Swimmer’s Shoulder
- Achilles Tendonitis
Reasons to subscribe to Australia tendonitis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia tendonitis treatment market databook
-
Our clientele includes a mix of tendonitis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia tendonitis treatment market, including forecasts for subscribers. This country databook contains high-level insights into Australia tendonitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia tendonitis treatment market report size, by treatment, 2018-2030 (US$M)
Australia Tendonitis Treatment Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
